[Federal Register: June 23, 2005 (Volume 70, Number 120)]
[Notices]
[Page 36389-36394]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23jn05-53]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
STD Surveillance Network (SSuN)
Announcement Type: New.
Funding Opportunity Number: AA055.
Catalog of Federal Domestic Assistance Number: 93.977.
Key Dates:
Letter of Intent Deadline: July 8, 2005.
Application Deadline: July 25, 2005.
I. Funding Opportunity Description
Authority: Sections 317(k)(2) and 318 of the Public Health Service
Act [42 U.S.C. Sections 247b(k)(2) and 247c], as amended.
Background: A dynamic STD surveillance network, comprised of local
enhanced STD surveillance systems following common protocols, has the
potential to fill several important gaps in the existing national STD
surveillance system. National STD surveillance data, reported through
the National Electronic Telecommunication Surveillance System (NETSS),
currently involves a limited number of demographic data elements
collected from all states for a limited number of sexually transmitted
diseases (chancroid, chlamydia, gonorrhea, and syphilis). Weekly
reporting through NETSS is insufficient for rapid identification of
many trends in disease, and does not support the collection and
reporting of data on many relevant STD risk behaviors. Furthermore,
even if trends in disease or risk behaviors are identified, the
national STD morbidity surveillance infrastructure comprised of NETSS
reporting from all states has limited capacity to be easily and rapidly
modified. Even though the transition to the National Electronic Disease
Surveillance System (NEDSS) is intended to improve the timeliness and
flexibility of national STD surveillance, the flexibility of national
morbidity reporting will always be restricted by the scale of the
system.
CDC has traditionally relied on supplemental activities such as
prevalence monitoring projects and special studies to enhance STD
surveillance at a national level. While these types of activities focus
on
[[Page 36390]]
specific at-risk sub-populations, an STD surveillance network would
focus activities on the larger population with disease. The STD
surveillance network would also have the ability to monitor what is
happening across the range of STD entities (gonorrhea, herpes,
chlamydia, syphilis, HPV, etc.). In addition, it should provide the
infrastructure and potential to detect emerging issues and
environmental changes (ex: increases in lymphogranuloma venereum (LGV),
resistant gonorrhea, resistant syphilis, HPV, illicit drug use). An
initial focus and priority would be to obtain enhanced data on
gonorrhea. Additional priority areas would be determined by the STD
surveillance network on an ongoing basis.
Purpose: The purposes of the program are to: develop a dynamic STD
surveillance network comprised of local enhanced STD surveillance
systems, following common protocols, to improve the capacity of
national, state, and local STD programs to detect, monitor, and respond
rapidly, flexibly, and with greater effectiveness to established and
emerging trends in sexually transmitted diseases (STDs) through
improved collection, reporting, analysis, visualization (i.e. mapping);
and interpret STD surveillance data.
This program addresses the ``Healthy People 2010'' focus area(s)
of: HIV Infection, Immunization and Infectious Diseases, Public Health
Infrastructure, and Sexually Transmitted Diseases.
Measurable outcomes of the program will be in alignment with one or
more of the following performance goals for the Coordinating Center for
Infectious Diseases (CCID), National Center for HIV, STD, and TB
Prevention (NCHSTP), Division of STD Prevention (DSTDP): (1) Reduce STD
rates by providing chlamydia and gonorrhea screening, treatment, and
partner treatment to 50 percent of women in publicly funded family
planning and STD clinics nationally; (2) Reduce the incidence of
primary and secondary syphilis; (3) Reduce the incidence of congenital
syphilis; and (4) Strengthen the capacity nationwide to monitor the
epidemic, develop and implement effective HIV prevention interventions,
and evaluate prevention programs.
This announcement is only for non-research activities supported by
CDC/ATSDR. If research is proposed, the application will not be
reviewed. For the definition of research, please see the CDC Web site
at the following Internet address: http://www.cdc.gov/od/ads/opspoll1.htm
.
Activities:
Required awardee activities for this program are as follows:
Participate in conference calls and a CDC-organized
meeting in the first quarter of the year one budget period to finalize
a common protocol for enhanced gonorrhea surveillance and for at least
one other emerging or existing STD area of concern. Types of data to be
collected under the common protocol for enhanced gonorrhea
surveillance, with relevance for other STDs may include: number and
gender of sex partners; presence or absence of symptoms; sites of
infection; STD/HIV infection history; level of education; internet
usage; history of incarceration; performance drug use; and illicit
substance use.
Provide the human and technical resources necessary for
collection, analysis, interpretation, and dissemination of enhanced
gonorrhea surveillance data from one or more STD clinics; it is also
desirable, but not required, that awardees conduct enhanced
surveillance of gonorrhea in one or more surrounding counties.
Awardees planning to conduct enhanced surveillance of GC
in surrounding counties should conduct surveillance on a representative
sample of patients with gonorrhea in the county in which the STD clinic
is located.
Collaborate with CDC and other awardees to identify other
STDs and sexual health issues of interest (ex: LGV, resistant
gonorrhea, resistant syphilis, increased illicit drug use), including
those for which rapid implementation of surveillance and/or prevention
activities are needed.
Collaborate with CDC and other awardees to expeditiously
develop common protocols to monitor and respond to STD-relevant trends.
Provide the human and technical resources necessary to
conduct enhanced surveillance for the collaboratively identified other
STDs and sexual health issues.
Work collaboratively with other awardees and CDC to
standardize behavioral risk domains and achieve standardization of
specific data elements.
Collaborate to develop and implement common data elements
and protocols.
Plan to use or build upon currently existing electronic
information systems for the collection, integration, analysis, and
reporting of enhanced surveillance data.
Electronically transmit data from STD surveillance
activities to CDC on a monthly basis in a mutually agreed-upon format.
Perform routine analyses of local STD surveillance data,
including spatial or outbreak detection analyses; and evaluate the
effectiveness of different methods of spatial or outbreak detection
analysis in improving STD surveillance and program activities.
Establish mechanisms by which STD enhanced and routine
surveillance data are shared with stakeholders.
Participate in annual collaboration meetings by reporting
preliminary data and the status of ongoing activities, and working with
other sites to develop or revise common enhanced surveillance activity
protocols.
In a cooperative agreement, CDC staff is substantially involved in
the program activities, above and beyond routine grant monitoring. CDC
Activities for this program are as follows:
Draft common protocols for enhanced gonorrhea
surveillance, in STD clinics and in counties, to be discussed and
modified by awardees through conference calls and a meeting with
awardees in the first quarter of the year one budget period.
Analyze data from all awardees, and share results with
stakeholders.
Identify emerging trends in STDs and sexual health issues
that merit further investigation by the STD surveillance network.
Coordinate the development of new common surveillance and
response protocols; standardization of data elements; and definition of
data reporting formats through collaboration with awardees.
Coordinate annual collaboration meetings to review and
plan program activities.
Collaborate directly in the publication and dissemination
of project findings and experiences.
Facilitate, where possible, and assist with the electronic
transmission of data to CDC.
II. Award Information
Type of Award: Cooperative Agreement. CDC involvement in this
program is listed in the Activities Section above.
Fiscal Year Funds: 2005.
Approximate Total Funding: $400,000 (This amount is an estimate for
the first 12-month budget period, and is subject to availability of
funds.)
Approximate Number of Awards: Five.
Approximate Average Award: $80,000, if enhanced county-level
surveillance is included; $60,000 for projects that don't include such
an activity. (This amount is for the first 12-month budget period, and
includes both direct and indirect costs.)
[[Page 36391]]
Floor of Award Range: None.
Ceiling of Award Range: $100,000 (This ceiling is for the first 12-
month budget period.)
Anticipated Award Date: August 31, 2005.
Budget Period Length: 12 months.
Project Period Length: Three years.
Throughout the project period, CDC's commitment to continuation of
awards will be conditioned on the availability of funds, evidence of
satisfactory progress by the recipient (as documented in required
reports), and the determination that continued funding is in the best
interest of the Federal Government.
III. Eligibility Information
III.1. Eligible Applicants
Limited competition. Only the 65 state, county, city, and
territorial health departments that are current recipients of
Comprehensive STD Prevention Systems grants may apply for this program
because participation in an STD surveillance network requires the
participating entity to have the legal and programmatic capacity to
collect and monitor health data, as well as the programmatic capacity
to respond to emerging trends in disease and risk behaviors.
III.2. Cost Sharing or Matching
Matching funds are not required for this program.
III.3. Other
If you are requesting a funding amount greater than the ceiling of
the award range, your application will be considered non-responsive and
will not be entered into the review process. You will be notified that
your application did not meet the submission requirements.
Special Requirements
If your application is incomplete or non-responsive to the special
requirements listed in this section, it will not be entered into the
review process. You will be notified that your application did not meet
submission requirements.
Late applications will be considered non-responsive. See
section ``IV.3. Submission Dates and Times'' for more information on
deadlines.
Letters of intent are requested.
Awardees must ensure that enhanced gonorrhea surveillance
activities occur in at least one STD clinic that diagnoses at least 150
cases of gonorrhea per year; and, if the awardee plans to work in the
surrounding county, the county in which the STD clinic is located
receives reports of at least 100 cases of gonorrhea per year from other
providers.
Participation in Outcomes Assessment through Systems of
Integrated Surveillance (OASIS) cooperative agreements 707,
99000, or 02211 is useful, but not required, for
meeting the requirements of this activity. If not a former OASIS
participant, the applicant should demonstrate that they have
significant experience conducting other types of enhanced STD
surveillance, analyzing enhanced STD surveillance data, and
disseminating findings to stakeholders.
Note: Title 2 of the United States Code Section 1611
states that an organization described in Section 501(c)(4) of the
Internal Revenue Code that engages in lobbying activities is not
eligible to receive Federal funds constituting an award, grant, or
loan.
IV. Application and Submission Information
IV.1. Address To Request Application Package
To apply for this funding opportunity use application form CDC
5161-1.
CDC strongly encourages you to submit your application
electronically by utilizing the forms and instructions posted for this
announcement at http://www.grants.gov.
Application forms and instructions are available on the CDC Web
site, at the following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm
.
If you do not have access to the Internet, or if you have
difficulty accessing the forms on-line, you may contact the CDC
Procurement and Grants Office Technical Information Management Section
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to
you.
IV.2. Content and Form of Submission
Letter of Intent (LOI): Your LOI must be written in the following
format:
Maximum number of pages: 1.
Font size: 12-point unreduced.
Single spaced.
Paper size: 8.5 by 11 inches.
Page margin size: One inch.
Printed only on one side of page.
Written in plain language, avoid jargon.
Your LOI must contain the following information:
Your intent to apply for this application.
The name of the project coordinator(s).
The name of any proposed collaborator(s).
The name, address, telephone, e-mail, and fax number of
the applicant's primary point of contact for writing and submitting the
application.
Application: You must submit a project narrative with your
application forms. The narrative must be submitted in the following
format:
Maximum number of pages: 20. If your narrative exceeds the
page limit, only the first pages which are within the page limit will
be reviewed.
Font size: 12 point unreduced.
Double spaced.
Paper size: 8.5 by 11 inches.
Page margin size: One inch.
Printed only on one side of page.
Held together only by rubber bands or metal clips; not
bound in any other way.
The funding opportunity title and number must appear on
the first page.
Your narrative should address activities to be conducted over the
entire project period, and must include the following items in the
order listed: Background/Need, Objectives, Plan, Method, Experience,
Timeline, Capacity, Evaluation Plans, Sustainability, and Line-Item
Budget with Justifications. More detailed descriptions of these items
are described in section V.1. ``Criteria'' of this announcement.
Additional information may be included in the application
appendices. The appendices will not be counted toward the narrative
page limit. This additional information includes:
Curriculum Vitas.
Organizational Charts.
Letters of Support.
You are required to have a Dun and Bradstreet Data Universal
Numbering System (DUNS) number to apply for a grant or cooperative
agreement from the Federal Government. The DUNS number is a nine-digit
identification number, which uniquely identifies business entities.
Obtaining a DUNS number is easy and there is no charge. To obtain a
DUNS number, access http://www.dunandbradstreet.com or call 1-866-705-
5711.
For more information, see the CDC Web site at: http://www.cdc.gov/od/pgo/funding/pubcommt.htm.
If your application form does not have a
DUNS number field, please write your DUNS number at the top of the
first page of your application, and/or include your DUNS number in your
application cover letter.
Additional requirements that may require you to submit additional
documentation with your application are listed in section ``VI.2.
Administrative and National Policy Requirements.''
IV.3. Submission Dates and Times
LOI Deadline Date: July 8, 2005.
[[Page 36392]]
CDC requests that you submit a LOI if you intend to apply for this
program. Although the LOI is not required, not binding, and does not
enter into review of your subsequent application, the LOI will be used
to gauge the level of interest in this program, and allow CDC to plan
the application review.
Application Deadline Date: July 25, 2005.
Explanation of Deadlines: LOIs and Applications must be received in
the CDC Procurement and Grants Office by 4 p.m. eastern time on the
deadline date.
You may submit your application electronically at http://www.grants.gov.
Applications completed online through Grants.gov are
considered formally submitted when the applicant organization's
Authorizing Official electronically submits the application to http://www.grants.gov.
Electronic application will be considered as having met
the deadline if the application has been submitted electronically by
the applicant organization's Authorizing Official to Grants.gov on or
before the deadline date and time.
If you submit your application electronically with Grants.gov, your
application will be electronically time/date stamped, which will serve
as receipt of submission. You will receive an e-mail notice of receipt
when CDC receives the application.
If you submit your LOI or application by the United States Postal
Service or commercial delivery service, you must ensure that the
carrier will be able to guarantee delivery by the closing date and
time. If CDC receives your submission after closing due to: (1) Carrier
error, when the carrier accepted the package with a guarantee for
delivery by the closing date and time; or (2) significant weather
delays or natural disasters, you will be given the opportunity to
submit documentation of the carrier's guarantee. If the documentation
verifies a carrier problem, CDC will consider the submission as having
been received by the deadline.
If you submit a hard copy application, CDC will not notify you upon
receipt of your submission. If you have a question about the receipt of
your LOI or application, first contact your courier. If you still have
a question, contact the PGO-TIM staff at: 770-488-2700. Before calling,
please wait two to three days after the submission deadline. This will
allow time for submissions to be processed and logged.
This announcement is the definitive guide on LOI and application
content, submission address, and deadline. It supersedes information
provided in the application instructions. If your submission does not
meet the deadline above, it will not be eligible for review, and will
be discarded. You will be notified that you did not meet the submission
requirements.
IV.4. Intergovernmental Review of Applications
Your application is subject to Intergovernmental Review of Federal
Programs, as governed by Executive Order (EO) 12372. This order sets up
a system for State and local governmental review of proposed federal
assistance applications. You should contact your state single point of
contact (SPOC) as early as possible to alert the SPOC to prospective
applications, and to receive instructions on your state's process.
Click on the following link to get the current SPOC list: http://www.whitehouse.gov/omb/grants/spoc.html
.
IV.5. Funding Restrictions
Restrictions, which must be taken into account while writing your
budget, are as follows:
Funds may not be used for research.
Reimbursement of pre-award costs is not allowed.
Funds may not be used for construction.
If you are requesting indirect costs in your budget, you must
include a copy of your indirect cost rate agreement. If your indirect
cost rate is a provisional rate, the agreement should be less than 12
months of age.
Guidance for completing your budget can be found on the CDC Web
site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/budgetguide.htm
.
IV.6. Other Submission Requirements
LOI Submission Address: Submit your LOI by express mail, delivery
service, fax, or e-mail to: Lori Newman, MD, Project Officer, CDC/
NCHSTP/DSTDP, Mailstop E-02, 1600 Clifton Road, Atlanta, GA 30333,
(404) 639-6183, (404) 639-8610 (fax); len4@cdc.gov.
Application Submission Address: CDC strongly encourages applicants
to submit electronically at: http://www.grants.gov You will be able to download a copy of the application package from http://www.grants.gov.,
complete it offline, and then upload and submit the application via the
Grants.gov site. E-mail submissions will not be accepted. If you are
having technical difficulties in Grants.gov, they can be reached by e-
mail at http:http://www.support@grants.gov">//www.support@grants.gov or by phone at 1-800-518-4726 (1-
800-GRANTS). The Customer Support Center is open from 7 a.m. to 9 p.m.
eastern time, Monday through Friday.
CDC recommends that you submit your application to Grants.gov early
enough to resolve any unanticipated difficulties prior to the deadline.
You may also submit a back-up paper submission of your application. Any
such paper submission must be received in accordance with the
requirements for timely submission detailed in Section IV.3. of the
grant announcement. The paper submission must be clearly marked:
``Back-Up for Electronic Submission.''
The paper submission must conform to all requirements for non-
electronic submissions. If both electronic and back-up paper
submissions are received by the deadline, the electronic version will
be considered the official submission.
It is strongly recommended that you submit your grant application
using Microsoft Office products (e.g., Microsoft Word, Microsoft Excel,
etc.). If you do not have access to Microsoft Office products, you may
submit a PDF file. Directions for creating PDF files can be found on
the Grants.gov Web site. Use of file formats other than Microsoft
Office or PDF may result in your file being unreadable by our staff.
Or:
Submit the original and two hard copies of your application by mail
or express delivery service to: Technical Information Management-PA
AA055, CDC Procurement and Grants Office, 2920 Brandywine Road,
Atlanta, GA 30341.
V. Application Review Information
V.1. Criteria
Applicants are required to provide measures of effectiveness that
will demonstrate the accomplishment of the various identified
objectives of the cooperative agreement. Measures of effectiveness must
relate to the performance goals stated in the ``Purpose'' section of
this announcement. Measures must be objective and quantitative, and
must measure the intended outcome. These measures of effectiveness must
be submitted with the application and will be an element of evaluation.
Your application will be evaluated against the following criteria:
Methods: (25 points total)
(a) To what extent does the applicant demonstrate that methods for
STD clinic-based surveillance, information management, and disease
investigation and response are flexible and could be adapted for other
types of enhanced STD and behavioral surveillance in such
[[Page 36393]]
settings? Has the applicant included letters from collaborating clinics
and county health departments that demonstrate their support? If the
application is from a county or a city, does the application include a
letter of support from the state? (15 points)
(b) The applicant should clearly indicate if their plans include
enhanced surveillance of gonorrhea from the surrounding county. If
included, what is the extent to which methods are sound and analyses
will describe a representative sample of persons reported to have
gonorrhea in the county? Has the applicant included letters from
collaborating facilities and county health departments that demonstrate
their support? (10 points)
Capacity: (20 points total)
(a) Is the proposed staff capacity sufficient to conduct enhanced
data collection, entry, cleaning, analysis, evaluation, and
dissemination? Does the project staff have the appropriate background,
experience, and time to perform the proposed work? (10 points)
(b) Does the applicant have existing information management systems
with the capacity to merge or integrate electronic data from providers,
laboratories, or other data sources? Does the applicant have a database
that can be queried, can generate line listed clinic visit/patient
data, and can easily be modified to incorporate new data elements? (10
points)
Objectives/Plan: (15 points total)
What is the quality of the proposed plan to participate in an
enhanced surveillance network to collect enhanced gonorrhea data, as
well as data on other emerging or existing STD issues? Consider clarity
of objectives and soundness of the applicant's approach. The applicant
should demonstrate an understanding of the potential utility of
enhanced STD surveillance at both the local and national level. The
applicant should indicate a willingness to collaborate with other
grantees funded for this project, and adhere to a common standard
protocol.
Experience: (15 points total)
Did the applicant participate in previous Outcomes Assessment
through Systems of Integrated Surveillance (OASIS) cooperative
agreements 707, 99000, or 02211, and
demonstrate their ability to successfully conduct enhanced gonorrhea
surveillance and work collaboratively with other sites? OR Does the
applicant demonstrate that they have significant experience conducting
other types of enhanced STD surveillance, analyzing enhanced STD
surveillance data, and disseminating findings to stakeholders?
Background/Need: (10 points total)
How well has the applicant described the target population, and
justified the need for this program within the target population? Is
the gonorrhea morbidity in the target population sufficient to merit
enhanced surveillance and subsequent interventions? To what extent does
the STD clinic have a large and varied clientele (with regard to
gender, race, ethnicity, and sexual orientation) who experience a range
of STDs, and a professional staff with the ability to recognize,
correctly diagnose, and treat emerging STDs and sexual issues? (Note:
It is required that the STD clinic see a minimum average of 150
patients of gonorrhea per year.) What is the STD burden in the
designated county? (Note: For awardees planning enhanced surveillance
in the county, the county must have at least an additional 100 reported
cases of gonorrhea a year reported from other providers.)
Evaluation Plans: (5 points total)
Has the applicant set forth clear performance goals? Has the
applicant outlined outcome measures that are objective, quantitative,
and adequately measure the intended outcome? To what extent does the
applicant demonstrate their ability and intent to disseminate and
translate the data into programmatic action?
Timeline: (5 points total)
Has the applicant proposed an achievable timeline? Has the
applicant documented their ability to implement the proposed plan for
enhanced gonorrhea surveillance within the first year of the project
period?
Sustainability: (5 points total)
To what extent has the applicant demonstrated that activities could
be institutionalized as ongoing surveillance activities?
Budget and Justification: (Reviewed, but not scored.)
Is the budget reasonable, clearly justified, and consistent with
the intended use of funds?
V.2. Review and Selection Process
Applications will be reviewed for completeness by the Procurement
and Grants Office (PGO) staff, and for responsiveness by NCHSTP/DSTDP.
Incomplete applications and applications that are non-responsive to the
eligibility criteria will not advance through the review process.
Applicants will be notified that their application did not meet
submission requirements.
An objective review panel of CDC employees will evaluate complete
and responsive applications according to the criteria listed in the
``V.1. Criteria'' section above. All members of the objective review
panel will come from outside of the funding division of NCHSTP.
In addition, the following factors may affect the funding decision:
The need for geographic diversity may affect applicant
selection.
Applicant selection may be affected by the importance of
covering high gonorrhea morbidity areas.
Applicant selection may be affected by the importance of
including populations that broadly represent patients with gonorrhea by
gender, race, ethnicity, and sexual orientation.
CDC will provide justification for any decision to fund out of rank
order.
V.3. Anticipated Announcement and Award Dates
August 31, 2005.
VI. Award Administration Information
VI.1. Award Notices
Successful applicants will receive a Notice of Award (NoA) from the
CDC Procurement and Grants Office. The NoA shall be the only binding,
authorizing document between the recipient and CDC. The NoA will be
signed by an authorized Grants Management Officer, and mailed to the
recipient fiscal officer identified in the application. Unsuccessful
applicants will receive notification of the results of the application
review by mail.
VI.2. Administrative and National Policy Requirements
45 CFR part 74 and part 92
For more information on the Code of Federal Regulations, see the
National Archives and Records Administration at the following Internet
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
The following additional requirements apply to this project:
AR-4 HIV/AIDS Confidentiality Provisions.
AR-6 Patient Care.
AR-7 Executive Order 12374 Review.
AR-9 Paperwork Reduction Act Requirements.
AR-10 Smoke-Free Workplace Requirements.
AR-11 Healthy People 2010.
Additional information on these requirements can be found on the
CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm
.
An additional Certification form from the PHS 5161-1 application
needs to be included in your Grants.gov electronic submission only.
Refer to http://www.cdc.gov/od/pgo/funding/
[[Page 36394]]
PHS5161-1Certificates.pdf. Once the form is filled out, attach it to
your Grants.gov submission as Other Attachment Forms.
VI.3. Reporting Requirements
You must provide CDC with an original, plus two hard copies of the
following reports:
1. Interim progress report, due by June 30th of each funding year.
The progress report will serve as your non-competing continuation
application, and must contain the following elements:
a. Current Budget Period Activities Objectives.
b. Current Budget Period Financial Progress.
c. New Budget Period Program Proposed Activity Objectives.
d. Budget.
e. Measures of Effectiveness.
f. Additional Requested Information.
2. Financial status report and annual progress report, due by
December 30 of each funding year.
3. Final financial and performance reports, no more than 90 days
after the end of the project period.
These reports must be mailed to the Grants Management or Contract
Specialist listed in the ``Agency Contacts'' section of this
announcement.
VII. Agency Contacts
We encourage inquiries concerning this announcement. For general
questions, contact: Technical Information Management Section, CDC
Procurement and Grants Office, 2920 Brandywine Road, Atlanta, GA 30341;
telephone: 770-488-2700.
For program technical assistance, contact: Lori Newman, MD, Project
Officer, Mailstop E-02, 1600 Clifton Road, Atlanta, GA 30333,
telephone: 404-639-6183; e-mail: len4@cdc.gov.
For financial, grants management, or budget assistance, contact:
Gladys Gissentanna, Grants Management Specialist, CDC Procurement and
Grants Office, 2920 Brandywine Road, Atlanta, GA 30341, telephone: 770-
488-2753; e-mail: gcg4@cdc.gov.
VIII. Other Information
This and other CDC funding opportunity announcements can be found
on the CDC Web site, Internet address: http://www.cdc.gov. Click on
``Funding'' then ``Grants and Cooperative Agreements.''
Dated: June 17, 2005.
William P. Nichols,
Director, Procurement and Grants Office, Centers for Disease Control
and Prevention.
[FR Doc. 05-12410 Filed 6-22-05; 8:45 am]
BILLING CODE 4163-18-P